Latest News about SNY
Recent news which mentions SNY
Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts
August 11, 2025
From Benzinga
From Benzinga
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
August 06, 2025
From Benzinga
Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales
August 06, 2025
From Benzinga
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts
August 03, 2025
From Motley Fool
Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients
August 01, 2025
From Benzinga
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
August 01, 2025
From Benzinga
Earnings Scheduled For July 31, 2025
July 31, 2025
From Benzinga
From Motley Fool
Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel
July 25, 2025
From Benzinga
From Benzinga
Why Thermo Fischer Stock Is Rising Wednesday
July 23, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Cogent's Chronic Immune Disorder Drug Has Strong Potential To Become A Blockbuster: Analyst
July 08, 2025
From Benzinga
Regeneron's Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myeloma
July 03, 2025
From Benzinga
Why This Biotech Stock Just Doubled In A Single Day
June 26, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial
June 11, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free